Would you give one breath if you could detect lung cancer and other diseases?
Introducing OneBreath™
A unique technology platform developed by Breath Diagnostics to quantitatively analyze organic compounds in a single breath to detect lung cancer and other diseases.1
Our highly portable system will be readily available to patients through medical providers.1
In contrast to a Low-Dose CT Scan, OneBreath is a quicker and easier way of lung cancer diagnosis. We are currently enrolling patients for our 2nd generation system Pilot Study.
Breath Collection
Patients provide one complete breath via a unique collection system in less than 30 seconds.
Breath Processing and Analysis
In a simple automated process, the OneBreath™ micro-reactor captures the organic compounds contained in the breath. Once captured, the samples is analyzed in our laboratories.
Get Results
Results will be available within 3-4 business days.
Why OneBreath™?
OneBreath™ provides a safe, convenient, and inexpensive way to identify lung cancer in at risk patients, before they know they have a problem.1
Accurate Results
OneBreath™ detects lung cancer with fewer false positives and higher specificity than a low-dose CT scan.
Accessible
The OneBreath™ system increases access to potentially life-saving lung cancer screenings by being portable enough for use in a physician's office or local pharmacy.
Affordable
The OneBreath™ technology platform demonstrates a lower false positive rate versus CT scans, reducing the number of unnecessary follow-up diagnostic procedures.
Easy to Use
The simplicity of the OneBreath™ system provides the potential to enhance screening compliance due to the fact that only a single breath is required.
Research & Publications
A comprehensive meta-analysis and systematic review of breath analysis in detection of COVID-19 through Volatile organic compounds
The COVID-19 pandemic had profound global impacts on daily lives, economic stability, and healthcare systems. Diagnosis of COVID-19 infection via RT-PCR was crucial in reducing spread of disease and informing treatment management. While RT-PCR is a key diagnostic test, there is room for improvement in the development of diagnostic criteria. Identification of volatile organic compounds (VOCs) in exhaled breath provides a fast, reliable, and economically favorable alternative for disease detection.
News
January 1, 2024
Wearable Breath Analysis?
Biomarkers in breath can be related to certain diseases, which makes breath-based analysis a powerful diagnostic tool. Here the milestones and remaining challenges are highlighted for the broad clinical implementation of wearables for breath analysis.
News
January 23, 2023
Testimonials
To the promise of breath based lung cancer diagnostics and what Breath diagnostics could offer patients
"Technology like OneBreath has so much potential for improving and saving lives."
Dr. Kevin Gardner
Executive VP Research and Innovation, University of Louisville
OneBreath™ by Breath Diagnostics
OneBreath™ may save your life.
Contact us to discover the future of lung cancer screening or click below to learn more.1
